BioLineRx Ltd (BLRX) — Financial Flexibility Index
BioLineRx Ltd (BLRX) has a Financial Flexibility Index of -0.18x as of December 2025. Free cash flow of $-3.20 Million (operating CF $-3.23 Million minus capex $25.20K) represents 0% of total liabilities ($17.56 Million). Also explore BLRX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioLineRx Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for BioLineRx Ltd across 18 annual periods. Check BLRX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioLineRx Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for BioLineRx Ltd. For the full company profile including market capitalisation, see BioLineRx Ltd (BLRX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.46x | $-8.11 Million | $-8.14 Million | $17.56 Million | ▲ +73.2% |
| 2024 | -1.72x | $-43.82 Million | $-43.87 Million | $25.45 Million | ▼ -291.4% |
| 2023 | -0.44x | $-22.31 Million | $-22.61 Million | $50.70 Million | ▲ +56.6% |
| 2022 | -1.01x | $-25.92 Million | $-26.24 Million | $25.54 Million | ▲ +42.5% |
| 2021 | -1.76x | $-23.48 Million | $-23.57 Million | $13.30 Million | ▼ -92.9% |
| 2020 | -0.91x | $-23.11 Million | $-23.21 Million | $25.26 Million | ▲ +18.3% |
| 2019 | -1.12x | $-22.59 Million | $-22.67 Million | $20.19 Million | ▼ -19.4% |
| 2018 | -0.94x | $-13.98 Million | $-24.19 Million | $14.91 Million | ▲ +53.5% |
| 2017 | -2.02x | $-16.31 Million | $-20.55 Million | $8.08 Million | ▲ +45.4% |
| 2016 | -3.70x | $-14.46 Million | $-14.51 Million | $3.91 Million | ▼ -19.2% |
| 2015 | -3.10x | $-11.45 Million | $-14.17 Million | $3.69 Million | ▲ +4.6% |
| 2014 | -3.25x | $-14.30 Million | $-14.48 Million | $4.40 Million | ▼ -33.5% |
| 2013 | -2.43x | $-20.12 Million | $-20.23 Million | $8.27 Million | ▼ -14.0% |
| 2012 | -2.14x | $-19.94 Million | $-20.11 Million | $9.34 Million | ▼ -32.9% |
| 2011 | -1.61x | $-10.94 Million | $-11.22 Million | $6.81 Million | ▼ -184.8% |
| 2010 | 1.90x | $12.12 Million | $11.46 Million | $6.40 Million | ▲ +196.2% |
| 2009 | -1.97x | $-21.45 Million | $-21.51 Million | $10.88 Million | ▲ +28.0% |
| 2008 | -2.74x | $-27.05 Million | $-27.96 Million | $9.89 Million | — |